Literature DB >> 33260159

Implication of integrins α3β1 and α5β1 in invasion and anoikis of SK-Mel-147 human melanoma cells: non-canonical functions of protein kinase Akt.

Nadezhda I Kozlova1, Galina E Morozevich1, Nina M Gevorkian1, Albert E Berman1.   

Abstract

Downregulation of integrins α3β1 and α5β1 strongly decreased cell colony formation and in vitro invasion and markedly enhanced anoikis in SK-Mel-147 human melanoma cells. These modifications were accompanied by a marked increase in the levels of active Akt protein kinase, which indicated it played a non-canonical function in the melanoma cells. Pharmacological inhibition of Akt1, an Akt isozyme, in cells depleted of α3β1 or α5β1 restored their invasive activity, while inhibition of the Akt 2 isoform did not cause a visible effect. Similar to our previous results with the α2β1 integrin, this finding suggested that in signaling pathways initiated by α3β1 and α5β1, the Akt1 isoform performs a non-canonical function in regulating invasive phenotype of melanoma cells. In contrast, when the effects of Akt inhibitors on anoikis of the melanoma cells were compared, the Akt2 isoform demonstrated a non-canonical activity in which Akt2 suppression led to a significant attenuation of apoptosis in cells with downregulated α3β1 or α5β1. Our results were the first evidence that, in the same tumor cells, different integrins can control various manifestations of tumor progression through distinct signaling pathways that are both common to various integrins and specific to a particular receptor.

Entities:  

Keywords:  anoikis; integrins; proteinkinases; tumor invasion

Mesh:

Substances:

Year:  2020        PMID: 33260159      PMCID: PMC7762463          DOI: 10.18632/aging.202243

Source DB:  PubMed          Journal:  Aging (Albany NY)        ISSN: 1945-4589            Impact factor:   5.682


  38 in total

1.  Implication of alpha5beta1 integrin in invasion of drug-resistant MCF-7/ADR breast carcinoma cells: a role for MMP-2 collagenase.

Authors:  G E Morozevich; N I Kozlova; I B Cheglakov; N A Ushakova; M E Preobrazhenskaya; A E Berman
Journal:  Biochemistry (Mosc)       Date:  2008-07       Impact factor: 2.487

Review 2.  ERKs in cancer: friends or foes?

Authors:  Xavier Deschênes-Simard; Filippos Kottakis; Sylvain Meloche; Gerardo Ferbeyre
Journal:  Cancer Res       Date:  2014-01-09       Impact factor: 12.701

Review 3.  Alpha2beta1 integrin in cancer development and chemoresistance.

Authors:  Dalila Naci; Kristiina Vuori; Fawzi Aoudjit
Journal:  Semin Cancer Biol       Date:  2015-08-20       Impact factor: 15.707

4.  Suppression of integrin alpha3beta1 in breast cancer cells reduces cyclooxygenase-2 gene expression and inhibits tumorigenesis, invasion, and cross-talk to endothelial cells.

Authors:  Kara Mitchell; Kimberly B Svenson; Whitney M Longmate; Katerina Gkirtzimanaki; Rafal Sadej; Xianhui Wang; Jihe Zhao; Aristides G Eliopoulos; Fedor Berditchevski; C Michael Dipersio
Journal:  Cancer Res       Date:  2010-07-14       Impact factor: 12.701

5.  Integrin alpha5/beta1 expression mediates HER-2 down-regulation in colon cancer cells.

Authors:  Scott K Kuwada; Jinqiu Kuang; Xiufen Li
Journal:  J Biol Chem       Date:  2005-03-09       Impact factor: 5.157

Review 6.  Integrins and cancer.

Authors:  Stergios J Moschos; Laura M Drogowski; Shelley L Reppert; John M Kirkwood
Journal:  Oncology (Williston Park)       Date:  2007-08       Impact factor: 2.990

7.  MicroRNA-26a promotes anoikis in human hepatocellular carcinoma cells by targeting alpha5 integrin.

Authors:  Xiang Zhang; Shu-Li Cheng; Ka Bian; Lei Wang; Xiao Zhang; Bo Yan; Lin-Tao Jia; Jing Zhao; Noor Gammoh; An-Gang Yang; Rui Zhang
Journal:  Oncotarget       Date:  2015-02-10

8.  Receptor tyrosine kinase Met promotes cell survival via kinase-independent maintenance of integrin α3β1.

Authors:  Lia Tesfay; Veronique V Schulz; Sander B Frank; Laura E Lamb; Cindy K Miranti
Journal:  Mol Biol Cell       Date:  2016-06-15       Impact factor: 4.138

Review 9.  Extracellular Matrix Alterations in Metastatic Processes.

Authors:  Mayra Paolillo; Sergio Schinelli
Journal:  Int J Mol Sci       Date:  2019-10-07       Impact factor: 5.923

Review 10.  p21 in Cancer Research.

Authors:  Bahar Shamloo; Sinem Usluer
Journal:  Cancers (Basel)       Date:  2019-08-14       Impact factor: 6.639

View more
  2 in total

1.  Integrin alpha9 emerges as a key therapeutic target to reduce metastasis in rhabdomyosarcoma and neuroblastoma.

Authors:  Natalia Navarro; Carla Molist; Júlia Sansa-Girona; Patricia Zarzosa; Gabriel Gallo-Oller; Guillem Pons; Ainara Magdaleno; Gabriela Guillén; Raquel Hladun; Marta Garrido; Miguel F Segura; Lourdes Hontecillas-Prieto; Enrique de Álava; Berta Ponsati; Jimena Fernández-Carneado; Ana Almazán-Moga; Mariona Vallès-Miret; Josep Farrera-Sinfreu; Josep Sánchez de Toledo; Lucas Moreno; Soledad Gallego; Josep Roma
Journal:  Cell Mol Life Sci       Date:  2022-10-11       Impact factor: 9.207

2.  Implication of integrin α2β1 in senescence of SK-Mel-147 human melanoma cells.

Authors:  Nadezhda I Kozlova; Galina E Morozevich; Albert E Berman
Journal:  Aging (Albany NY)       Date:  2021-07-13       Impact factor: 5.682

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.